Magnesium sulfate (oral)
Epsom Salts
- Dosage form
- Tablet
- Available strengths
- Typically dissolved as 1 to 3 level teaspoons (approximately 10-30 g) per dose
- Drug class
- Osmotic (saline) laxative
- Common brand
- Epsom Salts
Clinical overview. Oral magnesium sulfate (Epsom salts, dissolved in water) is a saline osmotic laxative that works the same way as magnesium citrate and magnesium hydroxide, drawing water into the bowel to produce a bowel movement, typically within 30 minutes to 6 hours. This entry covers oral laxative use only — it is a distinct use from intravenous magnesium sulfate given for conditions such as eclampsia or torsades de pointes, and from topical Epsom salt soaks.
Indication
Common therapeutic uses
- Relief of occasional constipation.
- This entry addresses the oral laxative use only, not the unrelated intravenous use of magnesium sulfate (e.g., eclampsia, severe asthma, arrhythmia) or its use as a topical soak.
Pregnancy
Risk assessment and monitoring considerations
- Limited data for the oral laxative use specifically; if a saline laxative is needed in pregnancy, this is generally reserved for short-term, occasional use after other measures have failed.
Breastfeeding
Infant exposure considerations
- Systemic absorption from the oral laxative dose is minimal; occasional use is generally considered compatible.
Geriatrics
Dosing and tolerability considerations
- Use with caution — confirm renal function before recommending regular use, given the risk of hypermagnesemia.
Pediatrics
Use in children and adolescents
- Use a reduced, weight-based dose in children 6 to 12 years under guidance; not established for routine use under age 6 except under medical direction.
Dosage & Administration
Practical dosing and administration
- Usual adult dose: 10 to 30 g dissolved in 240 mL of water or juice, PO once daily or in divided doses.
- Onset of effect is typically 30 minutes to 6 hours.
Overdose
Recognizing and responding to overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- Hypermagnesemia, particularly in renal impairment — lethargy, weakness, hypotension, and in severe cases respiratory depression or cardiac arrhythmia.
Common side effects
Frequently reported tolerability concerns
- Abdominal cramping, diarrhea, nausea.
Serious side effects
Findings that may require urgent assessment
Serious side effects require immediate discussion with the prescriber or emergency care.
- Hypermagnesemia in renal dysfunction.
- Dehydration and electrolyte disturbance with excessive or repeated use.
Use with caution
Situations requiring closer assessment
- Use with caution in renal impairment, cardiac disease, and older adults.
- Intended for occasional use only, not routine daily bowel management.
Contraindications
Situations where therapy may be inappropriate
- Avoid in renal failure (risk of hypermagnesemia).
- Do not use in bowel obstruction or symptoms suggestive of appendicitis.
Drug interactions
Clinically relevant combinations
- Decreases absorption of quinolone and tetracycline antibiotics — separate administration by at least 2 hours.
Food interactions
Meal-related administration
- Dissolve fully in water or juice before drinking; follow with additional fluid.
Time of administration
Practical scheduling
- Usually taken once, or in divided doses through the day, for occasional constipation.
Storage
Product handling
- Store the dry powder/crystals at room temperature in a dry container.
Patient take-away
Key counselling points for a quick closing summary
- This oral form of magnesium sulfate (Epsom salts dissolved in water) is a saline laxative that works within 30 minutes to 6 hours.
- This is different from Epsom salt used as a bath soak, and different from the intravenous magnesium sulfate used in hospitals — do not substitute one use for another.
- Avoid this product if you have kidney disease unless specifically directed by your healthcare provider.
- Take other antibiotics such as tetracyclines or quinolones at least 2 hours apart from this product.
References
Source material and product information
For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.